Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

The purpose of this study was to determine the maximum-tolerated dose of gemcitabine plus mitoxantrone in women with metastatic breast cancer (MBC) and to evaluate activity and toxicity of this combination in a phase II trial. Sixty-three patients with MBC, previously treated with chemotherapy inclu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lorusso, V, Crucitta, E, Silvestris, N, Catino, A, Caporusso, L, Mazzei, A, Guida, M, Latorre, A, Sambiasi, D, D'Amico, C, Schittulli, F, Calabrese, P, De Lena, M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2003
Soggetti:
Clinical
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2377160/
https://ncbi.nlm.nih.gov/pubmed/12592360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600780
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi